Search results
Dec 5, 2023 · NEWS & MEDIA. Novavax's Updated COVID-19 Vaccine Now Authorized in Canada. December 5, 2023. Novavax's updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming days.
Dec 5, 2023 · Novavax's first vaccine to protect against COVID-19, known as Nuvaxovid, was authorized for use in Canadians 18 and over by Health Canada in February 2022. Pfizer-BioNTech and Moderna's mRNA...
Dec 7, 2022 · Health Canada previously approved Nuvaxovid as a primary series in adults aged 18 and older in February 2022 and as a homologous booster in adults in November 2022. In Canada , Nuvaxovid will be manufactured locally at the Biologics Manufacturing Centre in Montreal .
Apr 20, 2022 · The current allocation of Novavax in Canada as of Apr. 14 is: Ontario: 30,000. Manitoba: 10,300. Alberta: 10,000. Quebec: 7,500. British Columbia: 6,600. Saskatchewan: 4,200. Northwest...
Feb 17, 2022 · Novavax ’s COVID-19 vaccine has been approved for use in adults aged 18 years of age and older in Canada. Health Canada updated the list of approved COVID-19 vaccines on Thursday to include ...
Oct 27, 2023 · On September 12 and 28, 2023, Health Canada authorized XBB.1.5-containing mRNA COVID-19 vaccine products (Moderna Spikevax 1.5 and Pfizer-BioNTech Comirnaty Omicron XBB.1.5 respectively) for use in individuals 6 months of age and older.
